This review outlines emerging pharmacological and nonpharmacological therapeutic options for heart failure and provides a clinical algorithm for evidence-based management.
Authors
No takes yet. Share an insight, caveat, or question.
May inform updated HF management algorithms; leaves open prospective validation of emerging therapies.
McMurray et al. (2002) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: